XS-02

N/A

Report date: 2026/05/07 20:00:36

Base Information

Drug NameXS-02
Drug Alias NameXS-02
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCheckpoint kinase 1 inhibitorsCheckpoint kinase 2 inhibitors
TargetsCheckpoint kinase 1Checkpoint kinase 2
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesXSXH Therapeutics Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesJiangsu Xingsheng Xinhui Pharmaceutical Co LtdXSXH Therapeutics Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A